导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 12.09% | 533/3266 |
| 近一周 | 0.25% | 489/3690 |
| 近一月 | -6.62% | 2820/3663 |
| 近一季 | -12.14% | 2653/3534 |
| 近半年 | 11.87% | 358/3357 |
| 近一年 | 16.03% | 540/3056 |
| 近两年 | 174.19% | 109/2167 |
| 近三年 | 124.62% | 51/1638 |
| 成立以来 | 93.03% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.45% 4142/4961 |
54.70% 499/5312 |
- - |
- - |
| 2025 | 67.95% 141/4813 |
5.10% 831/3635 |
1.33% 2376/4076 |
58.63% 146/4524 |
-0.59% 2554/4813 |
| 2024 | 20.69% 446/3463 |
-1.74% 1270/2808 |
-3.09% 1297/3014 |
15.35% 1744/3129 |
9.89% 301/3463 |
| 2023 | 11.50% 72/2656 |
38.64% 35/2280 |
-2.86% 693/2385 |
-14.36% 2182/2515 |
-3.33% 658/2655 |
| 2022 | -34.63% 1720/2207 |
-20.51% 1551/1919 |
-3.60% 1830/2016 |
-20.59% 1864/2113 |
7.42% 312/2208 |
| 2021 | 9.51% 455/1822 |
-6.43% 1000/1255 |
14.41% 257/1330 |
-8.02% 1095/1466 |
11.20% 90/1822 |
| 2020 | 20.99% 698/1250 |
3.19% 125/1028 |
20.51% 272/1067 |
-1.56% 1070/1164 |
-1.16% 1095/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 华夏中证人工智能主题ETF VS. 长安沪深300非周期A(740101) |